Novonesis AS - Director's Dealing 2024

Trading by management and close relations of management

In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B.

June 21, 2024

Company announcement No. 23


1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Novo Holdings A/S
2.	Reason for the notification
a)	Position/status	Novo Holding A/S is closely related to its CEO Kasim Kutay, who is a member of Novonesis' board of directors
b)	Initial notification/ Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Novozymes A/S, part of Novonesis Group
b)	LEI	529900T6WNZXD2R3JW38
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	B-Shares DK0060336014
b)	Nature of the transaction	Purchase of shares
c)	Price(s) and volume(s)	Price: 441.5135 Volume: 7,623,830 shares
d)	Aggregated information - Aggregated volume - Price	Number of shares: 7,623,830 Average price, DKK: 441.5135 Transaction value, DKK: 3,366,023,866
e)	Date of transaction	June 20, 2024
f)	Place of the transaction	Outside a trading window


Contact information
Tobias Bjorklund +45 3077 8682 [email protected]
Anders Enevoldsen +45 5350 1453 [email protected]
Disa Tuominen +45 6038 5826 [email protected]